Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Topic's Include: J&J says Covid booster shot is 94% effective in the U.S. when given two months after first dose, BLOOD DONORS NEEDED: Mayo Clinic asks community to step up during national blood shortage, and Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge.
In this episode of Lab Medicine Rounds, Chris Hartley, M.D., Assistant Professor of Laboratory Medicine and Pathology at Mayo Clinic, discusses the topic of cytopathology, and what some of the challenges and advancements are.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., talk about the potential for a fall uptick in respiratory viruses, such as the flu and RSV, and explain the protection that an influenza vaccine can offer.
Director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., joins a discussion about COVID-19 antibody testing in a recent story on NPR.
Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.
This week's research roundup features: Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study.
Topic's Include: COVID-19 media only news briefing: managing influenza during a pandemic, Mayo Clinic Q and A: COVID-19 vaccine boosters and third doses, and COVID Queries: Delta breakthrough infections.
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
Topic's Include: Biden: 2.8M people signed up for ObamaCare in special period, the pandemic marks another grim milestone of 1 in 500 Americans die of COVID-19, and understanding the delta variant, vaccines and breakthrough cases in Minnesota.
In this episode of Lab Medicine Rounds, Dr. Marshall Mazepa, Assistant Professor of Medicine at the University of Minnesota, discusses the topic of thrombotic thrombocytopenic purpura (TTP) and why it’s important to understand it.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update.
As a regulatory affairs coordinator in Quality Management Services, it’s Corrisa Miliander’s job to report diseases to each state across the country as required by law — a crucial role that supports public health agencies as they work to monitor and control outbreaks of communicable diseases.